Human Biological Samples (HBS) sit at the heart of clinical research, enabling the discovery, development and delivery of new treatments and diagnostics. As ethically sensitive materials, they underpin every clinical trial and demand rigorous handling and oversight. The Senior Biobank Scientist maintains and develops the HBS inventory in line with Good Clinical Practice (GCP), global standards and standard operating procedures (SOPs), ensuring samples are received, logged, stored, tracked, despatched, returned and disposed of appropriately.

About the Team

In service of its world-leading life sciences services, training, and research, the Applications team within ITS operates a substantial platform based on circa 120 Kubernetes clusters, combining a large VMware on-premises estate with a growing presence in public cloud.

We are now building upon this success and have launched a new, significant fundraising campaign. This campaign will help drive further transformational growth, from income across major donors, trusts and foundations, and corporate partners. Ultimately, it will help us fund cutting-edge research that will bring forward the day when we can diagnose, treat and prevent dementia.

Astex Pharmaceuticals is a world leader in innovative drug discovery and development. The company has successfully applied its proprietary Fragment-Based Drug Discovery platform to generate multiple new drug candidates that are progressing in clinical development. Successful collaborations have led to three launched oncology drugs (Kisqali® partnered with Novartis, Balversa® partnered with Janssen and Truqap™ partnered with AstraZeneca). Astex continues to grow and focuses on Neurological Disorders and Oncology.

The Role

Bicycle Therapeutics is a clinical-stage pharmaceutical company developing a novel class of medicines, referred to as Bicycle® molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This constraint facilitates target binding with high affinity and selectivity, making Bicycle molecules attractive candidates for drug development.

Have a look at their vacancies on their website.

About Healx
Healx is an AI-powered tech bio company redesigning drug discovery. With over 10,000 rare diseases affecting 400 million people globally - and 90% lacking approved treatments - our mission is to pioneer a new generation of drug discovery to bring treatments to patients faster.

We combine data, artificial intelligence and deep pharmacology expertise to develop therapies more efficiently and cost-effectively than traditional approaches.